首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >PRMT1-RBM15 axis regulates megakaryocytic differentiation of human umbilical cord blood CD34+ cells
【2h】

PRMT1-RBM15 axis regulates megakaryocytic differentiation of human umbilical cord blood CD34+ cells

机译:PRMT1-RBM15轴调节人脐带血CD34 +细胞的巨核细胞分化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Protein arginine methyltransferase 1 (PRMT1) serves pivotal roles in various cellular processes. However, its role in megakaryocytic differentiation has not been clearly reported. The aim of the present study was to explore the role of the PRMT-RNA binding motif protein 15 (RBM15) axis in human MK differentiation and the feasibility of targeting PRMT1 for leukemia treatment. In the present study, PRMT1 was overexpressed and the RBM15 protein was knocked down in human umbilical cord blood cluster of differentiation (CD)34+ cells and the cells were then cultured in megakaryocytic differentiation medium. Flow cytometry was used to analyze CD41 and CD42 double-positive cells, as well as the protein expression levels of PRMT1 and RBM15. The results demonstrated that human cord blood CD34+ cells differentiate into mature MKs in high thrombopoitin medium, as demonstrated by CD41 and CD42 expression. Overexpression of PRMT1 in human umbilical cord blood CD34+ cells blocked the maturation of megakaryocytic cells. Knockdown of RBM15 by short hairpin RNA produced less mature MKs. PRMT1 inhibitor rescued PRMT1-blocked megakaryocytic differentiation. These results provide evidence for a novel role of PRMT1 in the negative regulation of megakaryocytic differentiation. PRMT1 may be a therapeutic target for leukemia treatment.
机译:蛋白质精氨酸甲基转移酶1(PRMT1)在各种细胞过程中起关键作用。但是,尚未明确报道其在巨核细胞分化中的作用。本研究的目的是探讨PRMT-RNA结合基序蛋白15(RBM15)轴在人类MK分化中的作用以及靶向PRMT1进行白血病治疗的可行性。在本研究中,PRMT1在人脐带血分化细胞(CD)34 + 细胞中过表达,RBM15蛋白被敲低,然后在巨核细胞分化培养基中培养。流式细胞仪用于分析CD41和CD42双阳性细胞,以及PRMT1和RBM15的蛋白表达水平。结果表明,人脐血CD34 + 细胞在高血小板生成素培养基中分化为成熟的MKs,如CD41和CD42表达所证明。 PRMT1在人脐血CD34 + 细胞中的过度表达阻止了巨核细胞的成熟。短发夹RNA抑制RBM15产生的成熟MK较少。 PRMT1抑制剂挽救了PRMT1阻断的巨核细胞分化。这些结果为PRMT1在巨核细胞分化的负调控中的新作用提供了证据。 PRMT1可能是白血病治疗的治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号